Greylin Investment Management, Inc - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 26 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.

Quarter-by-quarter ownership
Greylin Investment Management, Inc ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$415,000
+501.4%
18,900
+83.5%
0.08%
+372.2%
Q1 2016$69,000
-46.9%
10,300
-32.0%
0.02%
-48.6%
Q4 2015$130,000
+4.0%
15,150
-33.6%
0.04%0.0%
Q3 2015$125,000
-51.2%
22,800
-49.4%
0.04%
-46.2%
Q2 2015$256,000
+12.3%
45,100
-9.8%
0.06%
+20.4%
Q1 2015$228,0000.0%50,0000.0%0.05%0.0%
Q4 2014$228,000
-68.7%
50,000
-44.1%
0.05%
-69.0%
Q3 2014$728,000
-17.0%
89,500
-1.9%
0.17%
-17.9%
Q2 2014$877,000
-12.5%
91,200
+7.4%
0.21%
-12.8%
Q1 2014$1,002,000
+25.6%
84,900
+64.2%
0.24%
+23.4%
Q4 2013$798,00051,7000.20%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Acrospire Investment Management LLC 8,355$61,0000.04%
TOCQUEVILLE ASSET MANAGEMENT L.P. 70,000$508,0000.01%
Financial Architects, Inc 2,000$15,0000.00%
FineMark National Bank & Trust 3,473$25,0000.00%
JFS WEALTH ADVISORS, LLC 1,000$7,0000.00%
Penserra Capital Management LLC 2,540$18,0000.00%
Tower Research Capital LLC (TRC) 1,284$10,0000.00%
SIMPLEX TRADING, LLC 2,673$19,0000.00%
Plante Moran Financial Advisors, LLC 300$2,0000.00%
Cutler Group LLC / CA 2,404$17,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders